These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25232903)

  • 1. Lower anti-HIV-1 neutralization in HIV-infected children with CD4+ T cell depletion: opposite correlation to that in adults.
    Agthe M; Nemes E; Jacob RA; Abrahams F; Fainguem N; Tetang SM; Cappelli G; Colizzi V; Dorfman JR
    AIDS; 2014 Jul; 28(11):1694-6. PubMed ID: 25232903
    [No Abstract]   [Full Text] [Related]  

  • 2. A single amino-acid change in a highly conserved motif of gp41 elicits HIV-1 neutralization and protects against CD4 depletion.
    Petitdemange C; Achour A; Dispinseri S; Malet I; Sennepin A; Ho Tsong Fang R; Crouzet J; Marcelin AG; Calvez V; Scarlatti G; Debré P; Vieillard V
    Clin Infect Dis; 2013 Sep; 57(5):745-55. PubMed ID: 23696512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies that cross-neutralize the tier-2 pseudoviruses are produced in antiretroviral-naïve HIV-1-infected children from northern India.
    Prakash SS; Andrabi R; Kumar R; Lodha R; Kabra SK; Vajpayee M; Luthra K
    Arch Virol; 2012 Sep; 157(9):1797-801. PubMed ID: 22674340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient neutralization of primary isolates by the plasma from HIV-1 infected Indian children.
    Prakash SS; Chaudhary AK; Lodha R; Kabra SK; Vajpayee M; Hazarika A; Bagga B; Luthra K
    Viral Immunol; 2011 Oct; 24(5):409-13. PubMed ID: 22004138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CD95 (APO-1/Fas) autoantibodies and T cell depletion in human immunodeficiency virus type 1 (HIV-1)-infected children.
    Stricker K; Knipping E; Böhler T; Benner A; Krammer PH; Debatin KM
    Cell Death Differ; 1998 Mar; 5(3):222-30. PubMed ID: 10200468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV neutralizing antibody titer during structured treatment interruption of highly active antiretroviral therapy.
    Nicastri E; Dori L; Buonomini AR; Tommasi C; De Nardo P; Bellagamba R; Corpolongo A; Montano M; Sordillo P; Volpi A; Sarmati L; Andreoni M
    AIDS; 2012 Jul; 26(11):1451-2. PubMed ID: 22767346
    [No Abstract]   [Full Text] [Related]  

  • 7. Apoptosis of CD4+ and CD19+ cells during human immunodeficiency virus type 1 infection--correlation with clinical progression, viral load, and loss of humoral immunity.
    Samuelsson A; Broström C; van Dijk N; Sönnerborg A; Chiodi F
    Virology; 1997 Nov; 238(2):180-8. PubMed ID: 9400591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
    Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of cross-reactive HIV-1-neutralizing activity in HIV-1-infected patients with rapid or slow disease progression.
    van Gils MJ; Euler Z; Schweighardt B; Wrin T; Schuitemaker H
    AIDS; 2009 Nov; 23(18):2405-14. PubMed ID: 19770692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV type 1 B'/C recombinant (CRF07_BC) in virologic noncontrollers elicits neutralizing antibodies against heterologous but not autologous viruses.
    Sun J; Ma L; Jiang S; Shao Y
    AIDS Res Hum Retroviruses; 2010 Feb; 26(2):237-9. PubMed ID: 20156107
    [No Abstract]   [Full Text] [Related]  

  • 12. Similar neutralizing activity in the HIV-1 infected long term non-progressors(LTNPs) and typical progressors(TPs).
    Wang Z; Li TY; Li JY; Chen LL; Liu YJ; Li HP; Bao ZY; Wang XL; Zhuang DM; Liu SY; Li L
    Virol Sin; 2012 Jun; 27(3):165-71. PubMed ID: 22684470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of binding of HIV-1 anti-p24 antibodies to CD4+ lymphocytes from HIV-infected subjects.
    Cameron PU; Hunter SD; Jolley D; Sonza S; Mijch A; Crowe SM
    Cytometry; 1998 Sep; 33(1):83-8. PubMed ID: 9725562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the rate of CD4+ T cell decrease and the year of human immunodeficiency virus (HIV) type 1 seroconversion among persons enrolled in the Swiss HIV cohort study.
    Vanhems P; Lambert J; Guerra M; Hirschel B; Allard R
    J Infect Dis; 1999 Dec; 180(6):1803-8. PubMed ID: 10558934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170).
    McLinden RJ; Paris RM; Polonis VR; Close NC; Su Z; Shikuma CM; Margolis DM; Kim JH
    AIDS; 2012 Jan; 26(1):1-9. PubMed ID: 21971356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infection.
    Vieillard V; Costagliola D; Simon A; Debré P;
    AIDS; 2006 Sep; 20(14):1795-804. PubMed ID: 16954720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralizing antibody patterns and viral escape in HIV-1 non-B subtype chronically infected treatment-naive individuals.
    Kelly HR; Urbanski M; Burda S; Zhong P; Konings F; Nanfack J; Tongo M; Kinge T; Achkar J; Nyambi P
    Hum Antibodies; 2005; 14(3-4):89-99. PubMed ID: 16720979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HIV-1 antibody avidity is correlated with clinical status in infected children.
    Sciascia C; Palomba E; Gay V; Tovo PA
    Pediatr AIDS HIV Infect; 1996 Feb; 7(1):14-9. PubMed ID: 11361468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low CD4 T-cell counts despite low levels of circulating HIV: insights from the comparison of HIV-1 infected patients with a discordant response to antiretroviral therapy to patients with untreated advanced HIV-2 disease.
    Albuquerque AS; Foxall RB; Cortesão CS; Soares RS; Doroana M; Ribeiro A; Lucas M; Antunes F; Victorino RM; Sousa AE
    Clin Immunol; 2007 Oct; 125(1):67-75. PubMed ID: 17692571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naive T lymphocytes and recent thymic emigrants are associated with HIV-1 disease history in french adolescents and young adults infected in the perinatal period: the ANRS-EP38-IMMIP study.
    Blanche S; Scott-Algara D; Le Chenadec J; Didier C; Montange T; Avettand-Fenoel V; Rouzioux C; Mélard A; Viard JP; Dollfus C; Bouallag N; Warszawski J; Buseyne F
    Clin Infect Dis; 2014 Feb; 58(4):573-87. PubMed ID: 24253249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.